Correlation Between Deciphera Pharmaceuticals and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Deciphera Pharmaceuticals and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deciphera Pharmaceuticals and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Deciphera Pharmaceuticals LLC and Emergent Biosolutions, you can compare the effects of market volatilities on Deciphera Pharmaceuticals and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deciphera Pharmaceuticals with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deciphera Pharmaceuticals and Emergent Biosolutions.
Diversification Opportunities for Deciphera Pharmaceuticals and Emergent Biosolutions
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Deciphera and Emergent is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Deciphera Pharmaceuticals LLC and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Deciphera Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deciphera Pharmaceuticals LLC are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Deciphera Pharmaceuticals i.e., Deciphera Pharmaceuticals and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Deciphera Pharmaceuticals and Emergent Biosolutions
Given the investment horizon of 90 days Deciphera Pharmaceuticals LLC is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, Deciphera Pharmaceuticals LLC is 2.53 times less risky than Emergent Biosolutions. The stock trades about -0.01 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 1,179 in Emergent Biosolutions on August 24, 2024 and sell it today you would lose (231.00) from holding Emergent Biosolutions or give up 19.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 32.06% |
| Values | Daily Returns |
Deciphera Pharmaceuticals LLC vs. Emergent Biosolutions
Performance |
| Timeline |
| Deciphera Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Emergent Biosolutions |
Deciphera Pharmaceuticals and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Deciphera Pharmaceuticals and Emergent Biosolutions
The main advantage of trading using opposite Deciphera Pharmaceuticals and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deciphera Pharmaceuticals position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.| Deciphera Pharmaceuticals vs. ANI Pharmaceuticals | Deciphera Pharmaceuticals vs. Phibro Animal Health | Deciphera Pharmaceuticals vs. Prestige Brand Holdings | Deciphera Pharmaceuticals vs. Evotec SE ADR |
| Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |